PipelineReview.com16d
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL
The existing data underscore its broad potential in both lymphomas and solid tumors. Notably, a ROR1 ADC combined with R-CHP has demonstrated an impressive complete response (CR) rate in a Phase II ...
bhg.com.au26d
Still using an iron? The 6 best garment steamers to use on shirts, delicates and more
Ironing clothes is arguably one of the worst household chores. Even though we love crisp white shirts and beautifully pleated linen pants just as much as the next person, they are very prone to ...
BBC1mon
'I make more in one hour on TikTok than a day in the shop'
"I make more in an hour going live, than a day spent in the shop," she said. A boom in online sales prompted Ms Mallows' decision to close her flagship beauty store in Cardiff, instead selling her ...
manilatimes1mon
BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
BR111 is an antibody-drug conjugate (ADC) targeting dual epitopes of ROR1, intended for the treatment of ROR1-positive hematological malignancies and solid tumors. ROR1 is a transmembrane receptor ...